What's breaking now, across thousands of outlets.
The next era of primary care will require intelligence that moves directly into the workflow, writes Sentara Health's head of ambulatory care.
We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.
'I can't go through World FTD Awareness Week without talking about Bruce. He is the driving force behind my advocacy,' Emma Heming Willis wrote.
Plus news about Regeneron. Summit Therapeutics to test cancer drug with Datroway: The biotech agreed to partner with AstraZeneca and Daiichi Sankyo on a clinical trial collaboration, testing its…
Settling for “good enough” undermines clinical trial quality in drug development and risks trial failure and regulatory rejection. Here’s what pursuing greatness actually requires.
Only a small fraction of young people with opioid use disorder receive addiction medications, and few stay on them for long, a study finds.
Stats SA says cardiovascular diseases accounted for 17.8% of registered deaths in South Africa in 2024, with hypertension and stroke among the leading causes.
The latest installment in BioPharma Dive’s data visualization series features a closer look at Kodiak’s stock performance and Hengrui's ties with U.S. and European drugmakers.
